- Home
- CCG vs XTNT Comparison
CCG vs XTNT Comparison
Compare CCG & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- XTNT
- Stock Information
- Founded
- CCG 2014
- XTNT N/A
- Country
- CCG China
- XTNT United States
- Employees
- CCG N/A
- XTNT N/A
- Industry
- CCG
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCG
- XTNT Health Care
- Exchange
- CCG Nasdaq
- XTNT Nasdaq
- Market Cap
- CCG 89.5M
- XTNT 89.8M
- IPO Year
- CCG N/A
- XTNT N/A
- Fundamental
- Price
- CCG $1.14
- XTNT $0.66
- Analyst Decision
- CCG Buy
- XTNT
- Analyst Count
- CCG 1
- XTNT 0
- Target Price
- CCG $350.00
- XTNT N/A
- AVG Volume (30 Days)
- CCG 507.9K
- XTNT 110.3K
- Earning Date
- CCG 11-25-2025
- XTNT 11-11-2025
- Dividend Yield
- CCG N/A
- XTNT N/A
- EPS Growth
- CCG N/A
- XTNT N/A
- EPS
- CCG N/A
- XTNT N/A
- Revenue
- CCG $444,290,042.00
- XTNT $127,766,000.00
- Revenue This Year
- CCG N/A
- XTNT $13.03
- Revenue Next Year
- CCG $7.06
- XTNT N/A
- P/E Ratio
- CCG N/A
- XTNT N/A
- Revenue Growth
- CCG N/A
- XTNT 15.16
- 52 Week Low
- CCG $0.66
- XTNT $0.33
- 52 Week High
- CCG $1.54
- XTNT $0.78
- Technical
- Relative Strength Index (RSI)
- CCG 46.81
- XTNT 60.69
- Support Level
- CCG $1.18
- XTNT $0.62
- Resistance Level
- CCG $1.35
- XTNT $0.67
- Average True Range (ATR)
- CCG 0.09
- XTNT 0.04
- MACD
- CCG -0.04
- XTNT 0.01
- Stochastic Oscillator
- CCG 8.33
- XTNT 85.79
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.